A health product with lung protection function and its preparation method and application
Through traditional Chinese medicine compositions of Polygonatum, Polygonatum and Licorice, health products with lung protection function are formed, which solves the problems of lung disease in traditional Chinese medicine that promotes lung qi and promotes fluid and nourishes lungs, significantly protects lung cells, and is suitable for a variety of lung diseases. Prevention and treatment of lung diseases.
Patent Information
- Application Number
- CN202211559597.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2022-12-06
- Publication Date
- 2024-11-05
- Estimated Expiration
- 2042-12-06
AI Technical Summary
The treatment of lung diseases in traditional Chinese medicine is difficult to effectively promote the reduction of lung qi, produce fluid and replenish the lungs, especially in symptoms such as abnormal qi rise and fall, yin fluid and depletion, cold evil invasion of the lungs, evil heat transfers to the lungs, and phlegm and turbidity blocking the lungs. The prior art is difficult to comprehensively prevent and protect lung health.
The traditional Chinese medicine compositions of Polygonatum, Polygonatum and Licorice are extracted and mixed by decoction or ultrasonic extraction to form health products with lung protection functions, which are used to prevent and treat cough, acute lung injury, chronic bronchitis, tuberculosis, Chronic obstructive pulmonary disease and lung diseases such as asthma.
It significantly protects lung cells, reverses nanosilicon dioxide and NNK-induced cell damage, has significant lung protection activity, is suitable for the prevention and treatment of a variety of lung diseases, and depends on the theory of traditional Chinese medicine to strengthen the foundation and chemopreventive effects.
Smart Images

Figure SMS_1 
Figure SMS_2 
Figure SMS_3
Abstract
Description
Technical Field
[0001] The invention belongs to the field of traditional Chinese medicine, and in particular relates to a health product with lung protection function and its preparation and application. Background Art
[0002] Lung-related diseases include a variety of diseases and related inflammations, including cough, acute lung injury, chronic bronchitis, tuberculosis, chronic obstructive pulmonary disease, and asthma. From the perspective of traditional Chinese medicine, the lung governs qi, controls breathing, controls water circulation, flows to all meridians, and governs the regulation of the body. It has the functions of dispersing and descending. Lung diseases are mostly characterized by abnormal qi movement, such as deficiency of lung qi, deficiency of yin fluid, cold evil invading the lung, evil heat invading the lung, and phlegm blocking the lung. When the lung fails to disperse and descend, it is easy to cough and wheeze, and then the water channel is not properly regulated, causing edema and urination difficulties; when the lung does not control qi, it will cause shortness of breath, spontaneous sweating, and easy cold; when the lung qi is out of balance and does not flow to all meridians, the heart and blood circulation will be unfavorable. Therefore, dispersing and descending lung qi, generating fluid and nourishing the lung, nourishing the deficiency and nourishing the essence, and strengthening the body and eliminating evil are the main treatment principles for lung diseases in clinical traditional Chinese medicine. Summary of the invention
[0003] The purpose of the present invention is to provide a health product with lung protection function and a preparation method and use thereof.
[0004] A health product with lung protection function is prepared from the following raw materials by weight: 8-15 parts of polygonatum, 10-17 parts of polygonatum odoratum and 10-15 parts of liquorice.
[0005] Preferably, the health care product with lung protection function is made of the following raw materials by weight: 9-11 parts of polygonatum, 11-13 parts of polygonatum odoratum, and 11-13 parts of liquorice.
[0006] Further preferably, the health product with lung protection function is made of the following raw materials by weight: 9 parts of polygonatum, 10 parts of polygonatum odoratum, and 11 parts of liquorice;
[0007] Further preferably, the health product with lung protection function is made of the following raw materials by weight: 10 parts of polygonatum, 12 parts of polygonatum odoratum, and 12 parts of liquorice;
[0008] Further preferably, the health care product with lung protection function is made of the following raw materials by weight: 11 parts of polygonatum, 12 parts of polygonatum odoratum, and 13 parts of liquorice.
[0009] A preparation method of a health product with lung protection function comprises the following steps: taking polygonatum, polygonatum odoratum and liquorice according to selected weight portions, mixing them and extracting them according to a conventional extraction method or extracting them respectively according to a conventional extraction method and then mixing them to obtain the health product.
[0010] Preferably, the conventional extraction method includes one or more of ultrasonic extraction, decoction, heating reflux extraction, percolation extraction and microwave extraction, wherein:
[0011] The extraction solvent is water or a methanol or ethanol solution with a volume percentage of 70-95%; the extraction times are 3-5 times; the time of each extraction is 60-120 minutes; the volume and weight ratio of the extraction solvent to the raw material medicine is 2-5L:1kg.
[0012] A preferred technical solution of the present invention is:
[0013] A method for preparing a health product with lung protection function comprises the following steps:
[0014] (1) Weighing polygonatum, polygonatum odoratum and liquorice according to the selected weight proportions, adding water, decocting for 60-80 minutes, filtering, and obtaining a filtrate and a residue;
[0015] (2) Take the residue obtained in step (1), add water, and boil for 60-80 minutes. Repeat the operation twice, and combine the obtained filtrates to obtain a medicinal solution.
[0016] Preferably, in step (1), before decocting, the step of soaking the raw material in water is also included, and the soaking time is 60-120 minutes.
[0017] Preferably, in step (2), after the water decoction is prepared, the method further comprises the steps of concentrating the water decoction to obtain an extract and drying the extract to obtain a fixed drug powder.
[0018] The present invention further provides the use of the above-mentioned Chinese medicine composition, or the Chinese medicine composition prepared by the above-mentioned preparation method in the preparation of drugs for prevention or lung protection.
[0019] Furthermore, the lung-related disease is at least one of cough, acute lung injury, chronic bronchitis, tuberculosis, chronic obstructive pulmonary disease and asthma.
[0020] The beneficial effects of the present invention are as follows: the present invention also provides any one of the health products (Chinese medicine composition) with lung protection function, and any one of the health products with lung protection function prepared by the preparation method, and their use in the preparation of drugs for prevention or lung protection. Preferably, the lung diseases involved in the lung protection include but are not limited to cough, acute lung injury, chronic bronchitis, tuberculosis, chronic obstructive pulmonary disease and asthma. The present invention is based on the TCM theory of "preventive treatment", comprehensively analyzes the clinical application characteristics of Chinese medicine in the treatment of lung diseases, selects Chinese medicine for strengthening the body and consolidating the lung meridian as the research object, and uses the constructed in vivo and in vitro lung cancer chemoprevention evaluation system to screen the activity of the Chinese medicine composition of polygonatum, polygonatum odoratum and liquorice. DETAILED DESCRIPTION
[0021] The following non-limiting embodiments may enable a person skilled in the art to more fully understand the present invention, but are not intended to limit the present invention in any way.
[0022] The test methods described in the following examples are conventional methods unless otherwise specified; the reagents and materials described are commercially available unless otherwise specified.
[0023] If no specific experimental steps or conditions are specified in the examples, the conventional experimental steps or conditions described in the literature in the field can be used. If no manufacturer is specified for the reagents or instruments used, they are all conventional reagent products that can be obtained commercially.
[0024] All medicinal materials have passed quality inspection and are in compliance with the standards of the Pharmacopoeia of the People's Republic of China.
[0025] Example 1 Chinese medicine composition
[0026] Ingredients: 30g Polygonatum sibiricum, 36g Polygonatum odoratum, 36g Licorice root.
[0027] Preparation method: Mix Polygonatum sibiricum, Polygonatum odoratum and Licorice, add water and boil for 3 times. For the first time, add 200 mL of water, soak for 60 minutes, and then boil for 80 minutes. For the second time, add 150 mL of water, boil for 60 minutes, and for the third time, add 100 mL of water, boil for 60 minutes. The decoctions obtained from the three times are all passed through a 100-mesh sieve, and the filtrates are combined to obtain the product.
[0028] Example 2 Chinese medicine composition
[0029] Ingredients: 27g Polygonatum sibiricum, 33g Polygonatum odoratum, 33g Licorice root.
[0030] Preparation method: Mix Polygonatum sibiricum, Polygonatum odoratum and Licorice, add water and boil for 3 times, add 180mL of water for the first time, soak for 80min, then boil for 90min, add 150mL of water for the second time, boil for 60min, add 100mL of water for the third time, boil for 60min. The decoctions obtained from the three times are all passed through a 100-mesh sieve, and the filtrates are combined to obtain the product.
[0031] Example 3 Chinese medicine composition
[0032] Ingredients: 30g Polygonatum sibiricum, 36g Polygonatum odoratum, 36g Licorice root.
[0033] Preparation method: Mix Polygonatum sibiricum, Polygonatum odoratum and Licorice, add water and ultrasonic extraction for 3 times, add 200mL of water for the first time, soak for 60min, then ultrasonic for 80min, add 150mL of water for the second time, ultrasonic for 60min, add 100mL of water for the third time, ultrasonic for 60min. The extracts obtained from the three times are all passed through a 100-mesh sieve, and the filtrates are combined to obtain the product.
[0034] Example 4 Chinese medicine composition
[0035] Ingredients: Polygonatum 33g, Polygonatum odoratum 39g, Licorice 39g.
[0036] Preparation method: Take Polygonatum sibiricum, Polygonatum odoratum and Licorice, add water and ultrasonic extraction for 3 times, add 50mL of water for the first time, soak for 60 minutes, and then ultrasonic for 80 minutes, add 50mL of water for the second time, ultrasonic for 60 minutes, and add 50mL of water for the third time, ultrasonic for 60 minutes. All the extracts obtained in the three times are passed through a 100-mesh sieve, and the filtrates are combined to obtain the product.
[0037] Example 5 Chinese medicine composition
[0038] Ingredients: 30g Polygonatum sibiricum, 36g Polygonatum odoratum, 36g Licorice root.
[0039] Preparation method: Mix Polygonatum sibiricum, Polygonatum odoratum and Licorice, add water and boil to extract 4 times, add 200mL of water for the first time, soak for 60min, then ultrasonic for 80min, add 150mL of water for the second time, ultrasonic for 60min, add 100mL of water for the third time, ultrasonic for 60min, add 100mL of water for the fourth time, ultrasonic for 60min. The extracts obtained in the four times are all passed through a 100-mesh sieve, and the filtrates are combined to obtain the product.
[0040] Example 6 Chinese medicine composition
[0041] Ingredients: 30g Polygonatum sibiricum, 36g Polygonatum odoratum, 36g Licorice root.
[0042] Preparation method: Take Polygonatum sibiricum, Polygonatum odoratum and Licorice, decoct and extract 3 times, add 200mL of water for the first time, soak for 60min, then ultrasonic for 80min, add 150mL of water for the second time, ultrasonic for 60min, add 100mL of water for the third time, ultrasonic for 60min. The extracts obtained from the three times are all passed through a 100-mesh sieve, and the filtrates are combined to obtain the product.
[0043] Example 1 Protective effect of the Chinese medicine composition of the present invention on cell damage caused by nano-silicon dioxide and NNK
[0044] 1. Experimental cells
[0045] Mouse normal alveolar type II epithelial MLE-12 cells were purchased from Shanghai Aoyin Biotechnology Co., Ltd.
[0046] 2. Experimental reagents
[0047]
[0048] 3. Experimental instruments
[0049]
[0050] 4. Cell culture
[0051] MLE-12 cells were taken out of liquid nitrogen, quickly revived in a 37°C water bath, and cultured in DMEM / F12 medium (containing 10% fetal bovine serum and 1% double antibody) at a concentration of 2.5×10 5 cells / mL, temperature: 37°C, CO 2 Content: 5%. When the adherent cells occupy about 80-90% of the bottom area of the culture flask on the third day, the adherent cells are digested with trypsin and subcultured to another culture flask.
[0052] 5. Preparation of Nano-Silica Particle Suspension
[0053] During the experiment, nm SiO 2 The particle suspension is prepared immediately before use. Weigh an appropriate amount of nm SiO 2 The particles were prepared with serum-free DMEM / F12 medium to a concentration of 20 μg / mL of nm SiO 2 Silicon stock solution (in vitro experiments) or 5% CMC-Na solution prepared at a concentration of 7 mg / mL nm SiO 2 The stock solution (in vivo experiment) was vortexed and ultrasonicated for 30 min to mix well for later use.
[0054] 6. MTT cell viability assay
[0055] (1) Cell viability assay
[0056] ① Inoculation of cells: MLE-12 cells in good growth state in the logarithmic growth phase were digested with 0.25% trypsin, and the culture medium was blown to disperse into a single cell suspension. After counting, the cell suspension was made into a single cell suspension with a density of 2.5×10 4 The cell suspension was inoculated into a 96-well plate, 100 μL per well, and placed in a 5% CO 2 The cells were cultured in a 37°C constant temperature incubator overnight.
[0057] ② Drug treatment: After the supernatant was removed on the second day, three different concentration gradients of the sample solution to be tested (10, 50, 100 mg / mL) were added, and three replicate wells were set up in parallel for each group. 5% CO 2 The cells were cultured in a 37°C constant temperature incubator for 24 h and the cell status was observed under a microscope.
[0058] ③MTT detection of cell viability: Add MTT solution (2 mg / mL) to a 96-well plate, 50 μL per well, 5% CO 2Incubate in a 37°C constant temperature incubator for 5 hours. After discarding the supernatant, add DMSO, 100 μL per well, and place on a shaker for 5 minutes to dissolve the purple formazan crystals. Finally, use an ELISA reader to measure the absorbance at a wavelength of 490 nm. Repeat the experiment 3 times.
[0059] ④Statistical analysis: GraphPad Prism 8.2.1 software was used to analyze the statistical results, and cell viability was calculated according to the following formula.
[0060]
[0061] (2)nm SiO 2 Induced cell damage experiment
[0062] The same operation as above was performed. The model group was added with the prepared 20 μg / mL nm SiO 2 Suspension, the drug group was added with 20 μg / mL nm SiO 2 The suspension was mixed with the test sample solutions of different concentrations (10, 50, 100 mg / mL).
[0063] (3) NNK-induced cell damage experiment
[0064] The same operation as above was performed. The NNK model group was added with the prepared 0.3 mg / mL NNK solution, and the drug administration group was added with 0.3 mg / mL NNK and 3 samples with different concentration gradients (10, 50, 100 mg / mL).
[0065] 7. Experimental results
[0066] Applicationnm SiO 2 The lung epithelial cell protective activity of the Chinese medicine composition was evaluated in the MLE-12 cell injury model induced by induced pulmonary epithelial cell injury. The test results showed that the composition could significantly reverse the nm SiO 2 The induced cell damage was concentration-dependent. The activity data are shown in Table 1.
[0067] Table 1 Effect of Chinese medicine composition on the survival rate (%) of MLE-12 cells (Mean±SEM)
[0068]
[0069] The lung epithelial cell protective activity of the Chinese medicine composition was evaluated using the NNK-induced MLE-12 cell injury model. The test results showed that at the administered concentration, the composition could significantly reverse NNK-induced cell damage and had a certain concentration dependence. The activity data are shown in Table 2.
[0070] Table 2 Effect of Chinese medicine combination on the survival rate (%) of MLE-12 cells (Mean±SEM)
[0071]
[0072] Example 2 Protective effect of the Chinese medicine composition of the present invention on cell damage caused by nano-silicon dioxide and NNK
[0073] 1. Experimental cells, reagents, instruments and methods are the same as those described in Example 1
[0074] 2. Experimental results
[0075] Applicationnm SiO 2 The lung epithelial cell protective activity of the Chinese medicine composition was evaluated in the MLE-12 cell injury model induced by induced pulmonary epithelial cell injury. The test results showed that the composition could significantly reverse the nm SiO 2 The induced cell damage was concentration-dependent. The activity data are shown in Table 3.
[0076] Table 3 Effect of Chinese medicine composition on the survival rate (%) of MLE-12 cells (Mean±SEM)
[0077]
[0078] The lung epithelial cell protective activity of the Chinese medicine composition was evaluated using the NNK-induced MLE-12 cell injury model. The test results showed that at the administered concentration, the composition could significantly reverse NNK-induced cell damage and had a certain concentration dependence. The activity data are shown in Table 4.
[0079] Table 4 Effect of Chinese medicine composition on the survival rate (%) of MLE-12 cells (Mean±SEM)
[0080]
[0081]
[0082] Example 3 Protective effect of the Chinese medicine composition of the present invention on cell damage caused by nano-silicon dioxide and NNK
[0083] 1. Experimental cells, reagents, instruments and methods are the same as those described in Example 1
[0084] 2. Experimental results
[0085] Applicationnm SiO 2The lung epithelial cell protective activity of the Chinese medicine composition was evaluated in the MLE-12 cell injury model induced by induced pulmonary epithelial cell injury. The test results showed that the composition could significantly reverse the nm SiO 2 The induced cell damage was concentration-dependent. The activity data are shown in Table 5.
[0086] Table 5 Effect of Chinese medicine composition on the survival rate (%) of MLE-12 cells (Mean±SEM)
[0087]
[0088] The lung epithelial cell protective activity of the Chinese medicine composition was evaluated using the NNK-induced MLE-12 cell injury model. The test results showed that at the administered concentration, the composition could significantly reverse NNK-induced cell damage and had a certain concentration dependence. The activity data are shown in Table 6.
[0089] Table 6 Effect of Chinese medicine composition on the survival rate (%) of MLE-12 cells (Mean±SEM)
[0090]
[0091] Example 4 Protective effect of the Chinese medicine composition of the present invention on cell damage caused by nano-silicon dioxide and NNK
[0092] 1. Experimental cells, reagents, instruments and methods are the same as those described in Example 1
[0093] 2. Experimental results
[0094] Applicationnm SiO 2 The lung epithelial cell protective activity of the Chinese medicine composition was evaluated in the MLE-12 cell injury model induced by induced pulmonary epithelial cell injury. The test results showed that the composition could significantly reverse the nm SiO 2 The induced cell damage was concentration-dependent. The activity data are shown in Table 7.
[0095] Table 7 Effect of Chinese medicine composition on the survival rate (%) of MLE-12 cells (Mean±SEM)
[0096]
[0097] The lung epithelial cell protective activity of the Chinese medicine composition was evaluated using the NNK-induced MLE-12 cell injury model. The test results showed that at the administered concentration, the composition could significantly reverse NNK-induced cell damage and had a certain concentration dependence. The activity data are shown in Table 8.
[0098] Table 8 Effect of Chinese medicine composition on the survival rate (%) of MLE-12 cells (Mean±SEM)
[0099]
[0100] Example 5 Protective effect of the Chinese medicine composition of the present invention on cell damage caused by nano-silicon dioxide and NNK
[0101] 1. Experimental cells, reagents, instruments and methods are the same as those described in Example 1
[0102] 2. Experimental results
[0103] Applicationnm SiO 2 The lung epithelial cell protective activity of the Chinese medicine composition was evaluated in the MLE-12 cell injury model induced by induced pulmonary epithelial cell injury. The test results showed that the composition could significantly reverse the nm SiO 2 The induced cell damage was concentration-dependent. The activity data are shown in Table 9.
[0104] Table 9 Effect of Chinese medicine composition on the survival rate (%) of MLE-12 cells (Mean±SEM)
[0105]
[0106] The lung epithelial cell protective activity of the Chinese medicine composition was evaluated using the NNK-induced MLE-12 cell injury model. The test results showed that at the administered concentration, the composition could significantly reverse NNK-induced cell damage and had a certain concentration dependence. The activity data are shown in Table 10.
[0107] Table 10 Effect of Chinese medicine composition on the survival rate (%) of MLE-12 cells (Mean±SEM)
[0108]
[0109] Example 6 Protective effect of the Chinese medicine composition of the present invention on cell damage caused by nano-silicon dioxide and NNK
[0110] 1. Experimental cells, reagents, instruments and methods are the same as those described in Example 1
[0111] 2. Experimental results
[0112] Applicationnm SiO 2 The lung epithelial cell protective activity of the Chinese medicine composition was evaluated in the MLE-12 cell injury model induced by induced pulmonary epithelial cell injury. The test results showed that the composition could significantly reverse the nm SiO 2The induced cell damage was concentration-dependent. The activity data are shown in Table 11.
[0113] Table 11 Effect of Chinese medicine composition on the survival rate (%) of MLE-12 cells (Mean±SEM)
[0114]
[0115] The lung epithelial cell protective activity of the Chinese medicine composition was evaluated using the NNK-induced MLE-12 cell injury model. The test results showed that at the administered concentration, the composition could significantly reverse NNK-induced cell damage and had a certain concentration dependence. The activity data are shown in Table 12.
[0116] Table 12 Effect of Chinese medicine composition on the survival rate (%) of MLE-12 cells (Mean±SEM)
[0117]
Claims
1. Use of a Chinese medicine composition in the preparation of a medicine having lung protection function, characterized in that: The lung protection function is the protection against lung epithelial cell damage caused by nano-silicon dioxide or NNK, wherein the Chinese medicine composition is prepared from the following raw materials by weight: 8-15 parts of polygonatum, 10-17 parts of polygonatum odoratum, and 10-15 parts of liquorice.
2. The use according to claim 1, characterized in that: The Chinese medicine composition is prepared from the following raw materials by weight: 9-11 parts of polygonatum, 11-13 parts of polygonatum odoratum, and 11-13 parts of liquorice.
3. The use according to claim 1, characterized in that: The Chinese medicine composition is made of the following raw materials by weight: 9 parts of polygonatum, 10 parts of polygonatum, 11 parts of liquorice; Or 10 parts of polygonatum, 12 parts of polygonatum, 12 parts of liquorice; Or 11 parts of polygonatum, 12 parts of polygonatum, and 13 parts of liquorice.
4. The use according to claim 1, characterized in that: The Chinese medicine composition is prepared by the following method: polygonatum sibiricum, polygonatum odoratum and liquorice are weighed according to the selected weight proportions, mixed and extracted according to a conventional extraction method or extracted separately according to a conventional extraction method and then mixed to obtain the Chinese medicine composition.
5. The use according to claim 4, characterized in that: The conventional extraction method includes one or more of ultrasonic extraction, decoction, heating reflux extraction, percolation extraction and microwave extraction, wherein: The extraction solvent is water or a methanol or ethanol solution with a volume percentage of 70-95%; the number of extractions is 3-5 times; the time for each extraction is 60-120 minutes; the volume and weight ratio of the extraction solvent to the raw material is 2-5L:1kg.
6. The use according to claim 4, characterized in that: The method comprises the following steps: (1) Weighing polygonatum, polygonatum odoratum and liquorice according to the selected weight proportions, adding water, decocting for 60-80 minutes, filtering, and obtaining a filtrate and a residue; (2) Take the residue obtained in step (1), add water, and boil for 60-80 minutes. Repeat the operation twice, and combine the obtained filtrates to obtain a medicinal solution.
7. The use according to claim 6, characterized in that: In the step (1), the step of soaking the raw material medicine in water before decocting is also included, and the soaking time is 60-120 minutes.
8. The use according to claim 6, characterized in that: In the step (2), after the water decoction is prepared, the method further comprises the steps of concentrating the water decoction to obtain an extract and drying the extract to obtain a fixed drug powder.
